Why the study?
Does an initial strategy of PCI plus medical therapy improve survival in patients with stable ischemic heart disease compared to medical therapy alone?
Does an initial strategy of PCI plus medical therapy improve survival in patients with stable ischemic heart disease compared to medical therapy alone?
An initial strategy of PCI added to medical therapy does not confer a long-term survival advantage over medical therapy alone in patients with stable ischemic heart disease.
Supports medical therapy alone for survival in stable ischemic heart disease; confirms no long-term PCI benefit in this RCT.
During an extended-follow-up of up to 15 years, we did not find a difference in survival between an initial strategy of PCI plus medical therapy and medical therapy alone in patients with stable ischemic heart disease. (Funded by the VA Cooperative Studies Program and others; COURAGE ClinicalTrials.gov number, NCT00007657.).
No takes yet. Share an insight, caveat, or question.
Sedlis et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: